Clinical Trials Logo

Short Bowel Syndrome clinical trials

View clinical trials related to Short Bowel Syndrome.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT01861834 Approved for marketing - Clinical trials for Cholestasis of Parenteral Nutrition

Safer Parenteral Nutrition in Pediatric Short Bowel Syndrome to Decrease Liver Damage

Start date: n/a
Phase:
Study type: Expanded Access

To provide children dependent on total parenteral nutrition with Omegaven®, a fish oil-based intravenous lipid emulsion that may be less hepatotoxic than conventional, vegetable oil-based intravenous lipid emulsions, and that may therefore reduce the need for liver transplantation.

NCT ID: NCT01297933 Approved for marketing - Clinical trials for Short Bowel Syndrome

Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease

Omegaven
Start date: n/a
Phase:
Study type: Expanded Access

A compassionate use protocol to provide Omegaven to pediatric patients with parenteral nutrition (PN) dependence and parenteral nutrition associated liver disease (PNALD).